Aptevo Therapeutics Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in th

Company Highlights
Year Founded

2016

icon-altStatus

Acquired

icon-altEmployees

61

Location (HQ)

USA

Since Last Funding

4 months

Monthly Website Visitors

2.6K

icon-altTotal Investment Amt

$57M

Last Funding Round

Post Ipo Equity

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biopharma

Biotechnology

Oncology

Biotechnology Research

Biometrics